The U.S. Food and Drug Administration has granted approval of the generic equivalent to TOBI® (Tobramycin Inhalation Solution USP) in the United States. Pursuant to an agreement with Novartis on this product, Teva expects to launch this product in late November
Just for the sake of argument, let's say you're right..and there is nothing here..so what? With the share
price movement lately,,,almost everyone is above water,,,and some are killing a bear being invested in
this stock..The analyst are behind this, the hedgies, and tutes are behind this,,All of Wall St. is behind
this,,and it's going to continue to run,,and hence make the stockholders more profits..We are getting paid.
This is what it's all about...or have you lost sight of that, or is that less important than you trying to get
everyone's goat? I for one wish you well, as it's easy for me to be gracious..I'm up over a million dollars
in the last year...Oh wait!!! your posts are supposed to make me sad..ok,,,boo hoo..feel better?
Missing the point as usual. Tobi is twice a day, Insmed product is one time. Matters not if their are ten Tobi suppliers, folks will seek one time daily treatment. You loose.